# Anti-Obesity Phentermine-Topiramate Extended Release Pharmacotherapy vs Placebo Among Patients Using a Wearable Activity Tracker

> **NCT04408586** · PHASE4 · COMPLETED · sponsor: **Mayo Clinic** · enrollment: 80 (actual)

## Conditions studied

- Obesity

## Interventions

- **DRUG:** Phentermine-Topiramate Extended Release
- **DRUG:** Placebo
- **OTHER:** Online support system

## Key facts

- **NCT ID:** NCT04408586
- **Lead sponsor:** Mayo Clinic
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-06-03
- **Primary completion:** 2022-06-13
- **Final completion:** 2022-10-11
- **Target enrollment:** 80 (ACTUAL)
- **Last updated:** 2023-06-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04408586

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04408586, "Anti-Obesity Phentermine-Topiramate Extended Release Pharmacotherapy vs Placebo Among Patients Using a Wearable Activity Tracker". Retrieved via AI Analytics 2026-08-18 from https://api.ai-analytics.org/clinical/NCT04408586. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*